2009 Medicare Budget Plan Pushes For ESA Bundling With Dialysis Rates
This article was originally published in The Pink Sheet Daily
Executive Summary
Single-payment proposal comes with no details on how the system would function.
You may also be interested in...
AMAG Pharmaceuticals Irons Out Ex-US Deal With Takeda For Feraheme
AMAG Pharmaceuticals announced April 1 it would team up with Takeda Pharmaceutical to commercialize its intravenous iron drug Feraheme (ferumoxytol) outside the US. A deal was not unexpected, as AMAG has signaled since winning approval from U.S. FDA in 2009 that the best way to maximize growth of Feraheme, especially in the European Union, is with a partner with global reach
AMAG Pharmaceuticals Irons Out Ex-US Deal With Takeda For Feraheme
Exclusive license adds to AMAG's cash reserves and further validates the anemia drug's safety profile
AMAG Pharmaceuticals Irons Out Ex-US Deal With Takeda For Feraheme
Exclusive license adds to AMAG's cash reserves and further validates the anemia drug's safety profile